Jessica Fye

Stock Analyst at JP Morgan

(4.01)
# 493
Out of 4,883 analysts
189
Total ratings
55.46%
Success rate
9.41%
Average return

Stocks Rated by Jessica Fye

Insmed
Jul 8, 2025
Maintains: Overweight
Price Target: $90$111
Current: $96.79
Upside: +14.68%
BeOne Medicines
Jun 27, 2025
Maintains: Overweight
Price Target: $317$321
Current: $245.07
Upside: +30.98%
Ionis Pharmaceuticals
Jun 12, 2025
Maintains: Neutral
Price Target: $45$48
Current: $41.58
Upside: +15.44%
Alnylam Pharmaceuticals
Jun 12, 2025
Maintains: Overweight
Price Target: $330$338
Current: $324.27
Upside: +4.23%
Moderna
May 22, 2025
Maintains: Underweight
Price Target: $33$26
Current: $33.17
Upside: -21.62%
BioNTech SE
May 22, 2025
Maintains: Neutral
Price Target: $120$116
Current: $111.61
Upside: +3.93%
Vertex Pharmaceuticals
May 6, 2025
Maintains: Overweight
Price Target: $512$515
Current: $467.09
Upside: +10.26%
BioCryst Pharmaceuticals
May 6, 2025
Maintains: Overweight
Price Target: $10$13
Current: $8.88
Upside: +46.40%
Ascendis Pharma
May 2, 2025
Maintains: Overweight
Price Target: $200$245
Current: $172.53
Upside: +42.00%
United Therapeutics
May 1, 2025
Maintains: Overweight
Price Target: $355$350
Current: $296.77
Upside: +17.94%
Maintains: Neutral
Price Target: $70$68
Current: $68.21
Upside: -0.31%
Maintains: Neutral
Price Target: $55$58
Current: $55.44
Upside: +4.62%
Maintains: Overweight
Price Target: $54$50
Current: $32.49
Upside: +53.92%
Maintains: Neutral
Price Target: $29$28
Current: $17.37
Upside: +61.20%
Maintains: Overweight
Price Target: $200$209
Current: $110.50
Upside: +89.14%
Maintains: Overweight
Price Target: $28$24
Current: $14.48
Upside: +65.75%
Maintains: Overweight
Price Target: $110$109
Current: $58.89
Upside: +85.09%
Maintains: Neutral
Price Target: $32$26
Current: $29.49
Upside: -11.82%
Initiates: Overweight
Price Target: $30
Current: $12.85
Upside: +133.46%
Maintains: Overweight
Price Target: $47$54
Current: $29.26
Upside: +84.55%
Maintains: Overweight
Price Target: $31$39
Current: $49.59
Upside: -21.36%
Maintains: Neutral
Price Target: $6$13
Current: $12.07
Upside: +7.71%
Reinstates: Underweight
Price Target: n/a
Current: $21.94
Upside: -
Reinstates: Underweight
Price Target: n/a
Current: $6.80
Upside: -
Reinstates: Neutral
Price Target: n/a
Current: $1.22
Upside: -
Reinstates: Underweight
Price Target: n/a
Current: $16.79
Upside: -
Maintains: Overweight
Price Target: $65$76
Current: $37.15
Upside: +104.58%
Downgrades: Underweight
Price Target: n/a
Current: $1.82
Upside: -
Initiates: Overweight
Price Target: $22
Current: $1.37
Upside: +1,505.84%
Upgrades: Neutral
Price Target: $7
Current: $0.91
Upside: +673.48%
Maintains: Overweight
Price Target: $32$27
Current: $30.01
Upside: -10.02%
Downgrades: Underweight
Price Target: n/a
Current: $0.31
Upside: -
Downgrades: Underweight
Price Target: n/a
Current: $7.12
Upside: -
Downgrades: Neutral
Price Target: n/a
Current: $7.81
Upside: -